DATA AVAILABILITY STATEMENT
Novartis is committed to sharing with qualified external researchers,
access to patient-level data and supporting clinical documents from
eligible studies. These requests are reviewed and approved by an
independent review panel on the basis of scientific merit. All data
provided is anonymized to respect the privacy of patients who have
participated in the trial in line with applicable laws and regulations.
This trial data availability is according to the criteria and process
described on
www.clinicalstudydatarequest.com